Demystifying Science: Understanding Downstream Processing ⭐

Down Stream
6 followers
8 Video Views·Jul 1, 2026
moving from growing cells to purifying the proteins they produce.
Join us in this conversation along with our host Dr.Kavita Rao in conversation with Anirudh Vasudevan, Downstream Function Lead, R&D at Biocon Biologics, as they demystify the critical steps of Downstream Processing — the science of purifying biologics.
AI Generated·May contain errors
Video Summary
AI GeneratedThis episode of \"Demystifying Science\" features Anirudh Vasudevan from Biocon Biologics, who explains the critical role of downstream processing in biopharmaceuticals. The discussion covers the journey from protein capture and purification to formulation, emphasizing the importance of scalability, real-time quality monitoring, and the professional mindset required for R&D success.
Welcome to another episode of Bioconversation's Demystifying Science.
As we continue our biologics journey, we will discuss about downstream processing today.
In a previous segment, we discussed about upstream processing starting from cell bank
to cell culture.
Once the protein is expressed, what happens next?
We will find out today from our guest, Mr. Anirudh Vasudevan, who will take us through
the next steps in bioprocessing, which is the downstream processing.
Welcome to our podcast, Anirudh.
Thanks Kavita for having me.
Sure.
So, Anirudh has a master's in chemical engineering from Arizona State University.
His experience ranges for 10 years, where he has worked in several industries.
He's a chemical engineer by training and here in Biocon Biologics R&D Bangalore, he is the
downstream functional lead.
Over to you Anirudh.
Hi, hi Kavita.
Thanks for having me.
It's really nice to be here.
I think this is the first time I'm doing something like this, so I'm excited to do this.
As we continue to demystify science for everyone.
So, I understand you were in Boston earlier, before your move to Bangalore.
From Boston to Bangalore, being a chemical engineer, to a downstream functional lead.
How has your experience been?
My experience has been very rewarding, but also very humbling, because I feel that, you
know, it has taught me to build on new strengths.
It has taught me to adapt.
It's much like, you know, how organizations are today, right, in terms of how you need
to be agile and being able to, you know, actually gain those new capabilities so that you can
still be competitive.
So definitely that's something that I'm very happy that I've had this experience.
So your chemical engineering background, bioprocessing background has actually helped you a lot in
taking up additional responsibilities in your current role.
Definitely, definitely.
I think that's what it is.
It's about building those new strengths and definitely the, it's about also mindset, right?
I mean, you want to kind of be in a place where you are able to have a mission, at least
I have a mission or a personal goal to ensure that, you know, we are doing something impactful.
So that's, that's what excites.
So for our viewers, would you help us understand what is downstream processing, and in very
simple terms.
Understood.
So the cells are grown in the bioreactor and they express the protein of interest and that
is so far upstream, right?
So downstream processing basically helps you capture this protein and purify these unwanted
things that, you know, the cells express.
And that's what we do in downstream process.
So why is it necessary to purify these cells?
So when I talk about these unwanted stuff, it is basically impurities, right?
So impurities are anything other than the protein of interest.
And these are not something that we want to have in our product that we are going to put
into our patients.
So it's important to have a process in place where these impurities are removed.
So that, you know, you're able to finally get a pure product that can be formulated
and given to our patients.
So when you say a pure product, so are we talking about relative purity or is it possible
to get a product that is 100% pure?
So when you look at the purity, you usually don't have 100% pure products.
This is not just what we do, but across the globe, there's always some level of impurity
that is there.
The goal is to get to a place where you're as close to a purity that, you know, where
you're confident of the safety, efficacy.
Which is desirable, essentially.
Exactly, exactly.
So that's where you want to get to.
And that's what the downstream process enables you to do.
So from your upstream, where you get those cells to your downstream, what exactly happens?
So upstream, what we're trying to do is, like I said, you're expressing the protein.
This protein gets expressed with a lot of other things also, like the unwanted stuff.
So these impurities can be anything, they can be cell debris, they can be other byproducts,
other proteins that, you know, the cells express.
So it becomes important for the downstream process to remove these, you know, impurities
and make that pure product.
And basically it's very simple.
So downstream processing uses a concept called separations.
So we use separations to ensure that, you know, these impurities are removed and you
only have the product in your final drug substance.
Okay.
So what are the steps involved in purifying?
I mean, you say separation, so what are the different types of separation technologies
that you employ in your downstream processing?
So when you talk about separations, it's basically exploiting differences between what you want,
which is your product, and all of this unwanted stuff, which is your impurities.
So this is your product impurities or the impurities that result from the process?
It can be both.
So when you look at the impurities, they can come either from the process itself, the cells
that, you know, you have the ingredients that go into the fermentation that, you know, help
you make these cells.
You create byproducts of those.
You also have some of these proteins that are not formed in exactly the way you want.
Right?
So all of these become impurities in the downstream process, which is what we try to remove.
So what we try to use is, you know, differences between the product and the impurities.
So it can be things like density, it can be size, it can be charge.
So there could be density differences, charge differences between your product of interest
and your impurities.
So you exploit that and employ those techniques that will help you discern this.
Exactly.
So some of these steps can be, I don't know, a centrifugation step or a crystallization
step or a chromatography step, right?
And these are all using different, you know, properties of those impurities and the product
to kind of separate and that's how you build the downstream process.
So you mentioned that you use a lot of chromatographic techniques in your separation, impurity separation.
So is it good to say that chromatographic techniques are the bread and butter of downstream
processing?
Definitely.
I think chromatography is a very critical step in downstream.
Chromatography offers a lot of advantages, right?
So you have a high level of selectivity, you have very good resolution of impurities, and
it's very scalable.
And these kind of properties really help it, you know, help us achieve our, you know, stringent
safety and quality standards, when I say quality or potency, purity, all of that comes
into it, right?
So you want to achieve all those standards and chromatography goes a long way in helping
us achieve that.
Having said that, there are different types of chromatography as well.
So you have ion exchange chromatography, size exclusion chromatography.
So there are several types of chromatography steps that are there.
And these steps, these different types of chromatography steps are then layered, so
that you form a sequence and have a downstream process so that you, you know, you get to
the product that you want.
So a smaller therapeutic peptide like an insulin or any peptide versus a monoclonal antibody
which is larger in size.
So does a downstream process change depending upon the size of the molecule?
Not necessarily.
The sequence of steps can be different and that is irrespective of whether it's an insulin
or a MAP.
I don't think that is, that plays into it very much.
It's about what is the complexity of the molecule and the complexity of the molecule then drives
what is the nature of the different steps that you have in the downstream process.
But it has all of these different steps.
You talk about filtrations, you talk about chromatography, you may have a crystallization.
So these steps are very common, commonly used across different therapeutic groups.
And so when you develop a particular process in your lab and you scale up.
So the magnitude of scale expands.
So how do you make that transition from your R&D to manufacturing?
That's a very good question.
So I think true success for a downstream process is its scalability, right?
Unless you're able to get it into manufacturing then you really don't have a process.
So I think there are a lot of things that you can do, but few important things that
you can consider while developing the process is understanding the risk, right?
Risk management becomes very important.
So you need to have a very good understanding of the unique complexity of your molecule.
You need to have conversations with your stakeholders who are your cross-functional teams or receiving
teams.
So who would those be?
In our case, it is usually our colleagues from the pilot plants, our colleagues in MSAT.
What is a pilot plant?
A pilot plant is a place where, you know, you're doing it in a lab scale, right?
Where you're talking about small beakers.
Smaller scales.
Very small beakers, very small equipment.
But the pilot scale is somewhere in between your lab scale and your manufacturing scale.
So it kind of helps you bridge the gap between the lab and your manufacturing.
So basically if you, instead of going at scale and understanding that some processes may
not work, you understand the feasibility at a mid-range.
Absolutely.
So I think the pilot scale helps you, you know, simulate some of these things that you
see at manufacturing, right?
So you know your product, you know the complexity it has.
You know those challenges that it may present.
So the pilot scale is a place where, you know, you can test out those hypotheses.
Make sure that you are ensuring that whatever you perceive as a risk, you are able to kind
of figure out a way to build a safeguard.
So that the risk is, you know, mitigated.
So is this the same thing that is called as a scale-down model?
A scale-down model is, yes, it's very similar to what I just described.
However, a scale-down model is something that is validated after the first scale-up actually
is done.
Because your material is coming from your scaled-up process.
You run it in parallel and say that, yeah, this is the thing I got here and this is what
I got here.
And you say that they are equal and that becomes your scale-down.
So how do you ensure the process that you have developed in the R&D, that's the originator
lab where you develop processes and screen processes.
So how do you know that, you know, the consistency and the quality is maintained from the lab
to manufacturing?
So when you, several parameters and several, you know, factors influence product quality
and process consistency, right?
So the goal in development is to ensure that these ranges and these parameters are optimized
and you are able to build in some amount of, you know, PAT tools or things like that, that
will help you.
PAT, sorry, PAT is?
PAT is Process Analytical Technology.
It is something that enables you to look at your process real-time, to check for its robustness,
check that it's okay behaving the same way that, you know, you envisioned it to be.
Are you able to see some drifts?
Are you able to see some changes?
So this helps us monitor that real-time to understand, okay, this is going fine, this
is not going fine.
This is something that we need.
So is this an industry accepted widely used in the industry?
Yeah, the industry now is moving towards PAT technologies because you want to reduce the
burden of in-process testing.
So you don't want to, you know, wait for something to come out and then make a decision and then
go forward.
You want your manufacturing operation to be very smooth.
So Process Analytical Technology really helps you de-bottleneck and move along to the next
step with confidence that you are able to have a robust output and you are getting the
required amount of quality.
Right.
So as I understand aggregates, protein aggregation is a very common phenomena, especially in
biotechnology.
So do you face that challenge even in your downstream processing where you experience
protein aggregation?
And we know that protein aggregation could begin to give a lot of problems.
Definitely aggregates are an important impurity or a critical quality attribute, we call it,
that we monitor in the downstream process.
So it is important that you are able to separate it from your product of interest.
And it's actually quite easy to separate also, in most cases, because you have a difference
in size.
Aggregate is basically a few proteins coming together.
So yeah, they will definitely be larger in size.
So therefore, you are going to have this difference between your product and these aggregates
which are going to be much larger in size.
So you can employ things like a filtration or even a size exclusion chromatography to
specifically remove these impurities.
Oh, that's interesting.
So what are the challenges that you most typically face in downstream processing?
Not one, I'm sure you have many.
But if you name a few challenges that, you know, that plague you on a day-to-day basis.
So downstream process is a little complex, right?
So you have a set of or a sequence of operations that you need to do.
And each kind of builds on the other in terms of, you start with a certain quality, and
then through each step, you kind of, you know, improve your quality, right?
So to ensure that that quality is maintained, while the process itself, the way you're doing
it is robust enough that, you know, small changes on the outside doesn't affect your output.
So that becomes very critical to, you know, manage.
And for that, we, you know, employ tools like quality by design, right?
So we take principles of quality by design.
It's nothing but just ensuring that you're able to catch critical process parameters
very early on.
So that you don't have to deal with it when you're at a much more mature stage of the
process development.
Correct.
So you have purified, it's, you've received, the end product of your purification train
or system is basically, it's a funneling approach.
You start with a very impure product, you reach a stage where your product is ultra
pure to the best of your capabilities and the best of the abilities of the process.
So when you do that, is that all that is required for, you know, taking the product to the market?
Not quite.
There's a very important step after that, right?
Which is formulation.
So we take care of the purity, but there's also the stability of the molecule in the
presentation that the patient sees.
So patient sees the product as a vial or, you know, as an injection or a tablet or,
you know, in case of an oral delivery, in case of biotech products, it's largely injectable.
So you would typically get it in different presentations.
So after this critical step, which is, I believe is one of the most critical steps of bioprocessing,
it is further processed into formulation.
Correct.
So formulation helps you get that stability, it helps you verify your dosage.
There's a lot of things that, you know, it's a whole different world compared to downstream.
And that becomes a very critical step so that you get the product in the way that you want.
So that, you know, there are no safety concerns, there's no potency concerns, there's no quality
concerns.
Which we will cover in our next segment.
Yeah, definitely.
I'm sure you'll have someone who's an expert at that to come and do the show.
So this has really been very helpful for us to understand what are the basics, you know,
of downstream processing.
We talk about downstream in a very large way and it's important to understand what are
the critical steps, what are the critical operations that we need to understand at
a larger level.
So before we break into our next segment, one rapid fire question for you is, what is,
you've been working for more than a decade in this industry, bioprocessing industry,
what is the most important skill?
You mentioned to me that you do multiple things, you do filtration, separation, crystallization
and QBD and PAT and all, so these are a lot of skills.
So what is the most important skill that you have developed across your experience that
you think is most valuable and has helped you grow in this role?
A couple of things, I think, you know, we need to ensure that we are doing the small
things right.
When we do our experiments, we need to ensure that we are able to identify why things are
failing, an experiment can fail.
But it's important to understand why it fails, what is the root cause for it.
So curiosity element.
Curiosity, definitely, curiosity and the second aspect is visualization, right?
So you're developing something, you want to put something out there in the world, right?
So visualizing that is a very powerful tool, it helps you look at it holistically in terms
of what needs to be out there and helps you make those adjustments that you need to ensure
that you are getting to what you intend to, you know, put out there.
So these two skills are very, you know, not a lot of people talk about it because we talk
about technical skills all the time, but these are more of, you know, very individuals, you
know, how they look at something and that really is what makes science very important
or the work that we do become very important to ensure that, you know, you're making what
you want.
True.
So these are largely technical, but one of the most important personal skill or strength
that you have been able to leverage in this role, what would that be?
For me, I think adaptability, I think I spoke about it earlier also, I think being adaptable
and being humble to know that, you know, things can change and to be perceptive of that and,
you know, being agile enough to understand that, okay, that is something that I need
to move towards.
I think that is very important to have the skills for that, you know, you continuously
be successful.
It's not about, you know, doing it right one time, but you need to sustain that and that
helps you.
Doing it right each time, every time.
So, you are in R&D, developing your, purifying your proteins, developing processes.
If I give you a day in your life, who would you trade your position with in the company?
Which function would that be?
Not a person, a function that you think, you know, you would like to experience just for
a day.
I mean, I'm experiencing this function for a day, which is, which has been amazing actually.
But from a customer-centric view, right, when you look at it, who are you giving your process
to?
It becomes your, like I said, your MSAT counterparts or your operations counterparts.
So, looking at, you know, the challenges and the problems from their perspective really
will help you, you know, become better.
So, I would like to, you know…
View it from their lens.
View from their lens.
You know, you interact with them, but you're always on the other side.
But to be on the other side, to actually face the challenges and go through what they do,
will give you a better appreciation for why you want, why they might want certain things.
Those nuances really get answered, if you can do that.
So thanks, Anirudh, for sharing your valuable insights on downstream processing and all
your other experiences that help shape this role and this function up, which is very critical.
So that's it from, for today, for this segment in downstream processing, until we meet in
the next segment, which will be the formulation development.
